217 related articles for article (PubMed ID: 27836726)
1. Differences in Env and Gag protein expression patterns and epitope availability in feline immunodeficiency virus infected PBMC compared to infected and transfected feline model cell lines.
Roukaerts IDM; Grant CK; Theuns S; Christiaens I; Acar DD; Van Bockstael S; Desmarets LMB; Nauwynck HJ
Virus Res; 2017 Jan; 227():249-260. PubMed ID: 27836726
[TBL] [Abstract][Full Text] [Related]
2. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
Flynn JN; Beatty JA; Cannon CA; Stephens EB; Hosie MJ; Neil JC; Jarrett O
AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1107-13. PubMed ID: 8554908
[TBL] [Abstract][Full Text] [Related]
3. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
Dean GA; LaVoy A; Burkhard MJ
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
[TBL] [Abstract][Full Text] [Related]
4. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
[TBL] [Abstract][Full Text] [Related]
5. gag- and env-specific serum antibodies in cats after natural and experimental infection with feline immunodeficiency virus.
Rimmelzwaan GF; Siebelink KH; Broos H; Drost GA; Weijer K; van Herwijnen R; Osterhaus AD
Vet Microbiol; 1994 Mar; 39(1-2):153-65. PubMed ID: 8203121
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.
Beatty JA; Willett BJ; Gault EA; Jarrett O
J Virol; 1996 Sep; 70(9):6199-206. PubMed ID: 8709246
[TBL] [Abstract][Full Text] [Related]
7. FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.
Lutz H; Hofmann-Lehmann R; Bauer-Pham K; Holznagel E; Tozzini F; Bendinelli M; Reubel G; Aubert A; Davis D; Cox D
Vet Immunol Immunopathol; 1995 May; 46(1-2):103-13. PubMed ID: 7618250
[TBL] [Abstract][Full Text] [Related]
8. Differences in feline immunodeficiency virus host cell range correlate with envelope fusogenic properties.
Pancino G; Castelot S; Sonigo P
Virology; 1995 Feb; 206(2):796-806. PubMed ID: 7856093
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus.
Cuisinier AM; Mallet V; Meyer A; Caldora C; Aubert A
Vaccine; 1997 Jul; 15(10):1085-94. PubMed ID: 9269051
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection.
Flynn JN; Cannon CA; Neil JC; Jarrett O
J Virol; 1997 Oct; 71(10):7586-92. PubMed ID: 9311839
[TBL] [Abstract][Full Text] [Related]
11. Properties and Functions of Feline Immunodeficiency Virus Gag Domains in Virion Assembly and Budding.
González SA; Affranchino JL
Viruses; 2018 May; 10(5):. PubMed ID: 29772651
[TBL] [Abstract][Full Text] [Related]
12. Retroviral vector-transduced cells expressing the core polyprotein induce feline immunodeficiency virus-specific cytotoxic T-lymphocytes from infected cats.
Li J; Brown WC; Song W; Carpino MR; Wolf AM; Grant CK; Elder JH; Collisson EW
Virus Res; 1995 Oct; 38(2-3):93-109. PubMed ID: 8578869
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C.
de Rozières S; Mathiason CK; Rolston MR; Chatterji U; Hoover EA; Elder JH
J Virol; 2004 Sep; 78(17):8971-82. PubMed ID: 15308694
[TBL] [Abstract][Full Text] [Related]
14. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
[TBL] [Abstract][Full Text] [Related]
15. Phylogenetic and genetic analysis of feline immunodeficiency virus gag, pol, and env genes from domestic cats undergoing nucleoside reverse transcriptase inhibitor treatment or treatment-naïve cats in Rio de Janeiro, Brazil.
Martins AN; Medeiros SO; Simonetti JP; Schatzmayr HG; Tanuri A; Brindeiro RM
J Virol; 2008 Aug; 82(16):7863-74. PubMed ID: 18550661
[TBL] [Abstract][Full Text] [Related]
16. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.
Lombardi S; Garzelli C; Pistello M; Massi C; Matteucci D; Baldinotti F; Cammarota G; da Prato L; Bandecchi P; Tozzini F
J Virol; 1994 Dec; 68(12):8374-9. PubMed ID: 7966629
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
[TBL] [Abstract][Full Text] [Related]
18. Detection of feline immunodeficiency virus subtypes A and B circulating in the city of Buenos Aires.
Huguet M; Novo SG; Bratanich A
Arch Virol; 2019 Nov; 164(11):2769-2774. PubMed ID: 31392428
[TBL] [Abstract][Full Text] [Related]
19. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.
Flynn JN; Keating P; Hosie MJ; Mackett M; Stephens EB; Beatty JA; Neil JC; Jarrett O
J Immunol; 1996 Oct; 157(8):3658-65. PubMed ID: 8871667
[TBL] [Abstract][Full Text] [Related]
20. Feline immunodeficiency virus Gag- and Env-specific immune responses after vaginal versus intravenous infection.
Burkhard MJ; Mathiason CK; Bowdre T; Hoover EA
AIDS Res Hum Retroviruses; 2001 Dec; 17(18):1767-78. PubMed ID: 11788028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]